Literature DB >> 3731069

Effects of normal human fibroblast mitochondrial DNA on segregation of HeLaTG Mitochondrial DNA and on tumorigenicity of HeLaTG cells.

J Hayashi, H Werbin, J W Shay.   

Abstract

We isolated hybrids and cybrids using HeLaTG cells and human normal primary fibroblasts to examine the functional differences between the mitochondrial genomes of tumor and normal cells with respect to their possible involvement in the regulation of tumorigenicity. Hybrids contained mitochondrial DNA (mtDNA) predominantly from the fibroblast parent and their tumorigenicity was suppressed completely. Then, cytoplasmic transmission of primary fibroblast mtDNA to HeLaTG cells was carried out using toxin-antitoxin selection. Two cybrid clones containing a HeLaTG nucleus only and more than 60% of transmitted fibroblast mtDNA were isolated and injected into nude mice to test their tumorigenicity. They formed tumors when 2 X 10(6) cells were injected, whereas no tumors were formed after injection of 5 X 10(5) cells (a concentration at which HeLaTG subclones formed tumors). These cybrids were cultivated in normal medium for two additional months and the content of fibroblast mtDNA increased gradually, resulting in HeLaTG mtDNA eventually being lost from both cybrid clones. We again examined their tumorigenicity and found that they recovered tumorigenicity completely. These results indicate that tumorigenicity of HeLaTG cells could not be suppressed by replacing their mitochondrial genomes with those of normal primary fibroblasts. Further, the partial suppression of tumorigenicity observed in the cybrid clones was temporary and may be due to cytoplasmic factors other than the mitochondrial genomes. Although we can find no difference between the mitochondrial genomes of normal and tumor cells regarding the regulation of tumorigenicity, the segregation pattern of the mtDNA in the cybrids was of interest: in the absence of any mitochondrial selection, HeLaTG mtDNA was lost while fibroblast mtDNA was retained, even though the nuclear component of these cybrids was from the HeLaTG cells. Thus, there should be some functional differences between the mitochondrial genomes of HeLaTG cells and primary fibroblasts that are responsible for the preferential segregation of HeLaTG mtDNA from the cybrids.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3731069

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Evaluation of mitochondrial content and activity with nonyl-acridine orange and rhodamine 123: flow cytometric analysis and comparison with quantitative morphometry. Comparative analysis by flow cytometry and quantitative morphometry of mitochondrial content and activity.

Authors:  G Lizard; Y Chardonnet; M C Chignol; J Thivolet
Journal:  Cytotechnology       Date:  1990-03       Impact factor: 2.058

2.  Introduction of disease-related mitochondrial DNA deletions into HeLa cells lacking mitochondrial DNA results in mitochondrial dysfunction.

Authors:  J Hayashi; S Ohta; A Kikuchi; M Takemitsu; Y Goto; I Nonaka
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

3.  Transcription and translation of deleted mitochondrial genomes in Kearns-Sayre syndrome: implications for pathogenesis.

Authors:  H Nakase; C T Moraes; R Rizzuto; A Lombes; S DiMauro; E A Schon
Journal:  Am J Hum Genet       Date:  1990-03       Impact factor: 11.025

Review 4.  Spotlight on the relevance of mtDNA in cancer.

Authors:  A Cruz-Bermúdez; R J Vicente-Blanco; E Gonzalez-Vioque; M Provencio; M Á Fernández-Moreno; R Garesse
Journal:  Clin Transl Oncol       Date:  2016-10-24       Impact factor: 3.405

Review 5.  Regulation of metastasis; mitochondrial DNA mutations have appeared on stage.

Authors:  Kaori Ishikawa; Hirotake Imanishi; Keizo Takenaga; Jun-Ichi Hayashi
Journal:  J Bioenerg Biomembr       Date:  2012-12       Impact factor: 2.945

6.  Trading mtDNA uncovers its role in metastasis.

Authors:  Kaori Ishikawa; Jun-Ichi Hayashi
Journal:  Cell Adh Migr       Date:  2009-01-21       Impact factor: 3.405

7.  Complementation of mutant and wild-type human mitochondrial DNAs coexisting since the mutation event and lack of complementation of DNAs introduced separately into a cell within distinct organelles.

Authors:  M Yoneda; T Miyatake; G Attardi
Journal:  Mol Cell Biol       Date:  1994-04       Impact factor: 4.272

8.  Experimental elongation of telomeres extends the lifespan of immortal x normal cell hybrids.

Authors:  W E Wright; D Brasiskyte; M A Piatyszek; J W Shay
Journal:  EMBO J       Date:  1996-04-01       Impact factor: 11.598

9.  Mitochondrial DNA mutations regulate metastasis of human breast cancer cells.

Authors:  Hirotake Imanishi; Keisuke Hattori; Reiko Wada; Kaori Ishikawa; Sayaka Fukuda; Keizo Takenaga; Kazuto Nakada; Jun-ichi Hayashi
Journal:  PLoS One       Date:  2011-08-11       Impact factor: 3.240

10.  Enhanced tumorigenicity by mitochondrial DNA mild mutations.

Authors:  Alberto Cruz-Bermúdez; Carmen G Vallejo; Ramiro J Vicente-Blanco; María Esther Gallardo; Miguel Ángel Fernández-Moreno; Miguel Quintanilla; Rafael Garesse
Journal:  Oncotarget       Date:  2015-05-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.